Torna al Registre Simple

 
dc.contributorVall d'Hebron Barcelona Hospital Campus
dc.contributor.authorGarrido, Pilar
dc.contributor.authorPaz-Ares, Luis
dc.contributor.authorMajem Tarruella, Margarita
dc.contributor.authorMorán, Teresa
dc.contributor.authorTrigo, José Manuel
dc.contributor.authorBosch-Barrera, J
dc.contributor.authorFelip Font, Enriqueta
dc.date.accessioned2022-02-01T13:21:37Z
dc.date.available2022-02-01T13:21:37Z
dc.date.issued2021-09
dc.identifier.citationGarrido P, Paz-Ares L, Majem M, Morán T, Trigo JM, Bosch-Barrera J, et al. LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology. Cancer Med. 2021 Sep;10(17):5878–88.
dc.identifier.issn2045-7634
dc.identifier.urihttps://hdl.handle.net/11351/6948
dc.descriptionMutacions de l'EGFR; Biòpsia líquida; Carcinoma de pulmó de cèl·lules no petites
dc.description.sponsorshipThis work was supported by Sysmex Inostics GmbH. The sponsor and the study coordinating investigators were involved in the study design and data interpretation. Writing and editorial assistance was funded by Sysmex Inostics GmbH.
dc.language.isoeng
dc.publisherWiley
dc.relation.ispartofseriesCancer Medicine;10(17)
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScientia
dc.subjectPulmons - Càncer - Prognosi
dc.subjectPulmons - Càncer - Tractament
dc.subjectADN - Anàlisi
dc.subject.meshCarcinoma, Non-Small-Cell Lung
dc.subject.meshNeoplasms
dc.subject.meshDNA Mutational Analysis
dc.titleLungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doi10.1002/cam4.4135
dc.subject.decscarcinoma de pulmón de células no pequeñas
dc.subject.decs/diagnóstico
dc.subject.decsanálisis de mutaciones del ADN
dc.relation.publishversionhttps://doi.org/10.1002/cam4.4135
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dc.audienceProfessionals
dc.contributor.organismesInstitut Català de la Salut
dc.contributor.authoraffiliation[Garrido P] Medical Oncology Department, IRYCIS Hospital Universitario Ramón y Cajal, Universidad Alcalá, Madrid, Spain. CIBERONC, Madrid, Spain. [Paz-Ares L] CIBERONC, Madrid, Spain. Medical Oncology Department, Hospital Universitario 12 de Octubre and i+12 Research Institute, Madrid, Spain. Lung Cancer Group, Clinical Research Program, Spanish National Cancer Research Center (CNIO), Madrid, Spain. Complutense University, Madrid, Spain. [Majem M] Medical Oncology Department, Hospital De La Santa Creu I Sant Pau, Barcelona, Spain. Spanish Lung Cancer Group (GECP), Barcelona, Spain. [Morán T] Spanish Lung Cancer Group (GECP), Barcelona, Spain. ICO Badalona, Hospital Germans Trias i Pujol, Barcelona, Spain. [Trigo JM] Medical Oncology Department, Hospital Universitario Virgen de la Victoria, Málaga, Spain. [Bosch-Barrera J] Medical Oncology, Catalan Institute of Oncology (ICO), Dr. Josep Trueta Hospital of Girona, Girona, Spain. [Felip E] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain
dc.identifier.pmid34296539
dc.identifier.wos000676107800001
dc.rights.accessrightsinfo:eu-repo/semantics/openAccess


Fitxers en aquest element

Thumbnail
Thumbnail

Aquest element apareix en la col·lecció o col·leccions següent(s)

Torna al Registre Simple